Home » Micromet Sticks to Tough Cancer Target
Micromet Sticks to Tough Cancer Target
Micromet is sticking to its research into cell adhesion antibodies to treat breast cancer and other tumours, hoping it will have more luck than GlaxoSmithKline and Centocor’s failed attempt.
BioPharma-Reporter.com
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May